The Department of Pharmaceuticals vide circular dated 18th February, 2022 has fixed the retail price, exclusive of Goods and Services Tax, of following formulation of goods.
- Paracetamol + Phenylephrine +Caffeine+Diphenhydramine Tablet
- Gliclazide ER + Metformin ER Tablet
- Chlorthalidone +Telmisartan +Amlodipine Tablet
- Telmisartan + Cilnidipine Tablet
- Gliclazide + Metformin Hydrochloride
- Atorvastatin & Clopidogrel Capsule
- Telmisartan, Cilnidipine & Metoprolol (ER) Tablets
- Telmisartan, Cilnidipine & Metoprolol (ER) Tablets
- Metformin + Glimepiride Tablet
- Atorvastatin & Clopidogrel Capsule
- Diclofenac Tablet
- Metformin + Glimepiride
- Telmisartan + Amlodipine +Hydrochlorothiazide Tablet
- Paracetamol + Thiocolchicoside Tablet
- Pantaprozole Dualrelease Gastro-resistant tablet (Aristo Pantop 80)
- Calcium, Vitamin D3, Mecobalamin, LMethylfolate Calcium & Diclofenac Transdermal Patch
- Diclofenac Diethylamine
- Paracetamol Infusion
The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price. The manufacturer shall issue a price list in Form–V to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
